# HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation

> **NCT03655145** · PHASE3 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 344 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Myeloproliferative Syndromes
- Myelodysplastic Syndromes

## Interventions

- **OTHER:** Haplo donor stem cell transplantation
- **OTHER:** HLA 10/10 MUD stem cell transplantation

## Key facts

- **NCT ID:** NCT03655145
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08
- **Primary completion:** 2019-06
- **Final completion:** 2023-06
- **Target enrollment:** 344 (ESTIMATED)
- **Last updated:** 2018-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03655145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03655145, "HLA 10/10 Matched Unrelated Donor vs Haploidentical Allogenic Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-07-21 from https://api.ai-analytics.org/clinical/NCT03655145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*